Chronic supraventricular tachycardia (SVT) causes left ventricular (LV) dilatation and dysfunction. Termination of SVT appears to reduce LV size and improve function. However, changes in myocyte structure and morphology that accompany the development and regression of SVTinduced cardiomyopathy have not been studied. Accordingly, we measured LV function using echocardiography and catheterization in three groups of six pigs each: 3 weeks of atrial pacing (SVT; 240 beats/min), 4-week recovery from SVT (PST), and sham-operated controls. At each of these three end points, isolated myocyte dimensions and nuclear number were measured using fluorescence, and the volume percent of myocytes and myofibrils was computed from tissue sections using stereological techniques. SVT resulted in reduced LV fractional shortening (15 ±3% versus 31±2%,p<0.05), increased end-diastolic dimension (5.6±0.8 versus 3.8±0.2 cm, p<0.05), and no change in mass (2.6±0.1 versus 2.6±0.2 g/kg,p=NS) compared with controls.
that termination of SVT in these animals resulted in improved ventricular function but was associated with persistent ventricular dilatation and the development of hypertrophy. 7 The myocyte is the cellular component of the ventricle responsible for active force production. Studies in animal models of hypertension or aortic stenosis have shown that in response to the chronic pressure overload, the myocyte hypertrophies, as manifested by an increase in cell surface area and volume.8'9 These changes in myocyte structure are closely associated with changes in ventricular structure and function.10 For example, pressure overload increases ventricular wall thickness, causes no change in ventricular chamber volume, and significantly increases ventricular mass.8-11 Because parallel changes between ventricular and myocyte morphology occur during pressure overload, we suspected that cellular and ventricular changes would parallel each other during the development and regression of tachycardia-induced cardiomyopathy. However, the precise nature of the remodeling that occurs with respect to the ventricular myocytes with the development of ventricular dysfunction and dilatation due to chronic SVT and after termination of the tachyarrhythmia is not known. Therefore, the purpose of this study was to examine the relation between ventricular and myocyte structure during the development and regression of tachycardia-induced dilated cardiomyopathy.
Materials and Methods

Experimental Preparation
Eighteen age-and weight-matched pigs (Yorkshire, [23] [24] [25] kg, 4 months old) were used in the study. Six animals were randomly assigned to each of three groups: 1) rapid atrial pacing (240 beats/min) for 3 weeks (SVT); 2) atrial pacing at 240 beats/min for 3 weeks, followed by deactivation of the pacemaker and a 4-week recovery period (PST); and 3) sham-operated controls. All animals were treated and cared for in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.12 Pacemakers were implanted or sham procedures were performed with animals anesthetized with isoflurane (2.0% at 1.5 1/min) and nitrous oxide (0.5 1/min). Animals were intubated, and through a left thoracotomy, a shielded stimulating electrode was sutured onto the left atrium, connected to a programmable pacemaker modified for programming heart rates up to 300 beats/min (Spectrax, Medtronic, Inc., Minneapolis, Minn.), and buried in a subcutaneous pocket. The pericardium was left open, the thoracotomy was closed, and the pleural space was evacuated of air. Seven to 10 days after animals had recovered from the surgical procedure, the protocols described above were begun. Cardiac auscultation and an electrocardiogram were performed frequently during the pacing protocol to ensure proper operation of the pacemaker and the presence of 1:1 conduction. Sham-operated controls were cared for in an identical fashion, with the exception of the pacing protocol.
Data Acquisition
On the day of study, animals were brought to the laboratory, an electrocardiogram was established, and the pacemaker was deactivated (SVT group only). After a 30-minute stabilization period, the animal was anesthetized with isoflurane (0.5% at 1.5 1/min) and ventilated through a nonrecirculating anesthesia circuit. Ventilation parameters were adjusted for maintenance of a pH of 7.38-7.45, a Pco2 of 35-40 mm Hg, and a Po2 of 200-300 mm Hg. Both carotid arteries were exposed. An externally calibrated micromanometer-tipped transducer (PPG Biomedical Systems, Pleasantville, N.Y.) and a fluid-filled catheter were placed into the left ventricle. Internal calibration of the micromanometer was performed with the fluid-filled catheter. After calibration, the fluid-filled catheter was placed in the aorta. Between studies, the micromanometer-tipped catheter was immersed in a water bath at 37°C under constant electrical excitation, then balanced and calibrated immediately before use. Pressures from the fluid-filled aortic catheter were obtained with an externally calibrated transducer (Statham P231D, Gould Instruments, Oxnard, Calif.) and a pressure amplifier (78304A, Hewlett-Packard Co., Andover, Mass.). The electrocardiogram and pressure waveforms were recorded with a multichannel recorder (FWR3701, Western Graphtec, Inc., Irvine, Calif.).
Two-dimensional and M-mode echocardiographic studies (Ultramark VI, 2.25-mHz transducer, Advanced Technology Laboratories, Bothell, Wash.) were used to image the left ventricle from a right parasternal approach. Measurements were made with criteria from the American Society of Echocardiography.13 Simultaneous dimension, thickness, and pressure recordings were obtained at 100 mm/sec for subsequent digitization and analysis. Left ventricular (LV) fractional shortening was computed as (enddiastolic dimension-end-systolic dimension)/(enddiastolic dimension) and was expressed as a percent. Peak +dP/dt was computed by differentiating LV pressure with respect to time. Circumferential, global average wall stress (cr, in grams per square centimeter) was computed at end systole and end diastole with a spherical model14:
where P is pressure, D is the minor axis dimension, and h is wall thickness.
After echocardiographic and catheterization measurements were collected, a sternotomy was performed, the heart was quickly extirpated and placed in a phosphate-buffered ice slush, and the coronary arteries were flushed. The great vessels were removed at the aortic and pulmonary valves, and the left ventricle was weighed quickly. The region of the LV free wall incorporating the circumflex artery (Sx5 cm) was excised and prepared for myocyte isolation. From the remainder of the LV free wall, three full-thickness sections (2x2 cm) were taken, immersed in 10% buffered formalin for 3 hours, and then transferred to 70% ethanol. These sections then were processed for staining and stereological analysis. In addition, three fullthickness sections (2x2 mm) were minced finely, immersed for 2 hours in a buffered sodium cacodylate solution containing 2% paraformaldehyde and 2% glutaraldehyde solution (pH 7.4, 750 mosm), and were prepared for electron microscopy. Finally, a 2x4-cm section was taken for the measurement of water content. These sections were weighed, placed in a 37°C oven, dried for 48 hours, and reweighed. Water content was determined as (wet wt-dry wt)/(wet wt) and is expressed as a percent. Ventricular Section Analysis Light microscopy. The tissue was processed for light microscopic examination through graded ethanols, was cleared in xylenes, and was embedded in paraffin. Slices 4 ,um in thickness were cut from the blocks, mounted on glass slides, and stained with hematoxylin and eosin for morphometric analysis. These sections were mounted on an inverted microscope (IM-35, Zeiss, Oberkochen, FRG), and circumferentially oriented myocytes along the subendocardium were imaged using an epifluorescence illuminator with a rhodamine filter at a magnification of x 630. The image then was analyzed with the computer image analysis system described above. Epifluorescence provided a high contrast between the myocytes and the extracellular space, allowing for simple and reliable digitization of the myocyte profiles. Ten random fields of circumferentially oriented myocytes along the subendocardial layer were examined from each slide and digitized. The sample field area was 7,600 um', and the system was calibrated with a stage micrometer before each digitizing session. Three slices at 1, 2, and 3 mm deep from each tissue block were examined. With this method, nine full-thickness sections from the left ventricle of each animal were examined. With computer-aided stereology, the volume percent of myocytes occupying the LV free wall was computed. '5 The total LV myocardial volume was computed by dividing LV weight by the specific gravity of muscle tissue: 1.06 g/ml.16 Total myocyte volume was computed as the product of LV myocardial volume and the morphometrically determined percent area of myocytes.15 Total water content was determined in a similar fashion.
Electron microscopy. Tissue sections fixed for electron microscopy were rinsed in 0.1 M phosphate buffer, postosmicated for 1 hour in 1% osmium tetroxide, dehydrated in an ascending series of alcohols, and embedded in Spurr's resin (Ladd Research Industries, Inc., Burlington, Vt.). Thick sections were taken from these tissue blocks at a thickness of 1 ,um, stained with toluidine blue, and viewed at x 100 to obtain areas of the tissue blocks where myofibers were oriented in a longitudinal or circumferential direction. Six tissue blocks in the circumferential and three blocks in the longitudinal orientation from the left ventricle of each pig then were used to obtain thin sections for electron microscopy. Three grids, containing three thin sections each, were prepared from each block. Thin sections were stained with uranyl acetate and lead citrate and examined with a 100S electron microscope (JEOL U.S.A., Inc., Peabody, Mass.). The central portion of each section was photographed at a calibrated magnification of x 10,000. These electron micrographs then were coded, and this code was not broken until the completion of the study. From the circumferentially oriented micrographs, the percent volume of myofibrils within myocytes was analyzed morphometrically by using a stereology sampling grid consisting of 140 sampling points.815 The total volume of LV myofibrils was computed as the product of total myocyte volume (computed from light microscopic morphometry) and the percent volume of myofibrils.
Myocyte Isolation and Examination
Myocytes were isolated using a modified version of a previously described method. 17 The left circumflex coronary artery was cannulated and the tissue rinsed free of blood with 35 ml of a modified Kraftbruhe salt-free bovine serum albumin).'8 Collagenase (0.5 mg/ml, Worthington type II; 146 units/mg) then was added to 75 ml of the modified KB solution, and the tissue was perfused with the collagenase solution for 35 minutes. The tissue then was minced into 2-mm sections and was added to an oxygenated trituration solution of fresh KB solution containing 2% bovine serum albumin, deoxyribonuclease II (DNase, 51 Kunitz units/ml, type IV, Sigma Chemical Co., St. Louis, Mo.), 300 ,M CaCl2, and 0.5 mg/ml collagenase. The tissue and trituration solution was transferred to a centrifuge tube and gently agitated. After 15 minutes, the supernatant was removed and filtered, and the cells were allowed to settle. The myocyte pellet then was resuspended in Dulbecco's modified Eagles medium: nutrient mixture F-12 (GIBCO Laboratories, Grand Island, N.Y.) supplemented with transferrin (5 ,ug/ml), insulin (5 ug/ml), sodium selenite (5 ng/ml), 3,3',5-triiodo-L-thyronine (4 pg/ml), hydrocortisone (36 ng/ml), bovine serum albumin (3%), and DNase (71.4 Kunitz units/ml). The number of cells was counted at x 100 magnification with a hemocytometer (Reichert-Jung, Cambridge Instruments Inc., Buffalo, N.Y.).
Three coverslips were coated with Matrigel (Collaborative Research Inc., Bedford, Mass.) and incubated at 37°C for 1 hour. Isolated cells (5 x 104 cells/ml) were plated onto the treated coverslips and incubated at 37°C. After 1 hour, the coverslips were irrigated with modified KB solution to remove unattached myocytes. Only those cells attached to the Indexes of ventricular function were compared among the three groups with a one-way analysis of variance. Analysis of the morphological data was performed with the average measurements obtained for each animal, and the three groups were compared with analysis of variance. A pilot study of three control hearts that used the morphometric sampling techniques described above resulted in less than an 8% coefficient of variation for the parameters computed in this study. Before the analysis of variance on the morphometric data was performed, homogeneity of variances of each morphometric variable for the three groups was confirmed with Bartlett's test. 24 If the analysis of variance revealed significant differences, pairwise tests of individual group means were compared using Tukey's procedure.24 Nuclear number per myocyte is a discrete variable, and therefore a frequency distribution for the total number of myocytes analyzed for this parameter was constructed. Changes in the number of nuclei per myocyte among the three groups were examined using x2 analysis. 24 Results are presented as mean+SEM. Values of p<0.05 were considered statistically significant.
Results
All of the animals in the pacing protocol developed congestive heart failure as evidenced by dyspnea, ascites, and peripheral edema within 17-20 days of pacemaker activation. These symptoms and signs resolved in all of the animals in the PST group.
Echocardiographic-catheterization studies were performed successfully in all of the animals. Ventricular Function Table 1 summarizes the ventricular function data obtained from the three groups. LV fractional shortening significantly decreased after 3 weeks of chronic SVT, and after a 4-week recovery period, fractional shortening returned to control values. LV end-diastolic pressure, dimension, and wall stress all were significantly increased after 3 weeks of chronic SVT compared with controls. In the PST group, LV end-diastolic pressure, dimension, and wall stress decreased compared with SVT values (p<0.05). However, end-diastolic dimension remained significantly higher than controls. Although chronic SVT resulted in significant chamber dilatation, wall thickness decreased, with no change in the LV wt/body wt ratio. In contrast, termination of SVT and a 4-week recovery period resulted in a significant increase in LV wall thickness and mass compared with controls. Table 2 summarizes results from the morphological examination of LV sections taken from the three groups. Absolute LV myocardial volume significantly increased in the SVT group as compared with controls. However, this increase in myocardial volume with SVT was accompanied by a significant reduction in the percent volume of myocytes occupying the LV wall. Thus, the increased LV myocardial volume and the decreased percent volume of myocytes in the SVT group resulted in no significant change in total LV myocyte volume from control values. The percent volume of myofibrils significantly decreased with SVT compared with control values. This reduction in myofibrillar percent volume in the SVT group resulted in a significant decline in total LV myofibril volume compared with the control group. Myocardial water content significantly increased with SVT as compared with controls. Therefore, the increased absolute LV myocardial volume with chronic SVT was associated with significantly reduced LV myofibril volume and significantly increased myocardial water content.
Myocardial and Myocyte Morphology
In the PST group, absolute LV myocardial volume significantly increased from both control and SVT values. The percent volume of myocytes increased from SVT values and was not significantly different from controls. The increased myocardial volume in conjunction with a normalization of the percent volume of myocytes resulted in a 37% increase in total myocyte volume in the PST group. Similarly, the percent volume of myofibrils in the PST group returned to control values and resulted in a significantly increased total LV myofibril volume compared with the control and SVT groups. Despite the significant increase in LV myocardial volume, there was no significant difference in myocardial water content between the PST and SVT groups. Thus, in contrast to the SVT group, the significantly increased absolute LV myocardial volume in the PST group was associated with significantly increased LV myocyte and myofibril volumes, with no change in myocardial water content. Myocytes were isolated successfully from all hearts obtained in this study, yielding an average of 62±6% quiescent, rod-shaped myocytes for study from each group. Figure 1 shows representative photomicrographs of myocytes harvested from control, SVT, and PST left ventricles. Table 3 summarizes data from the myocyte morphometric analysis. Myocytes from SVT hearts were significantly longer, with no significant difference in cell diameter. The increased myocyte length in the SVT group resulted in a higher cell surface area compared with control myocytes, but this difference did not reach statistical significance (p=0.25). This increased myocyte length resulted in significant increased computed myocyte volume in the SVT group compared with controls. The increased isolated myocyte volume and reduced total LV volume of myocytes with chronic SVT resulted in a significant reduction in the computed number of myocytes within the LV wall compared with controls. After termination of SVT (PST), cell length fell significantly from SVT values but remained significantly higher than controls. In the PST group, myocyte diameter and profile surface area all were significantly higher than control values. Myocyte diameter and surface area were greater in the PST group compared with the SVT group, but this did not reach statistical significance (p=0.18). These changes in myocyte diameter and length in the PST group resulted in a significantly increased cell volume from both the control and SVT groups. The total number of LV myocytes in the PST group was very similar to the SVT value and was significantly lower than control values. Thus, chronic SVT resulted in an increase in isolated myocyte volume but a reduction in the total number of myocytes within the LV wall. Nuclear number and the nuclear area/myocyte area ratio are shown for the three groups in Table 3 . In control myocytes, the mean number of nuclei per significantly with SVT; however, the nuclear area/ myocyte area ratio significantly increased. In the PST group, nuclear number significantly increased, and the nuclear area/myocyte area ratio was significantly reduced from both control and SVT values. Discussion The most important findings of this study were that 1) chronic SVT resulted in LV dysfunction and dilatation that was accompanied by significant changes in myocyte structure and myocardial composition, 2) termination of SVT subsequent to the development of dilated cardiomyopathy improved LV function but was accompanied by ventricular and myocyte hypertrophy, and 3) increased nuclear area occurred with SVT, but LV myocyte and myofibrillar volumes decreased, whereas regression from SVTinduced cardiomyopathy was associated with nuclear hyperplasia and significantly increased LV myocyte and myofibrillar volumes.
The combination of functional and morphometric studies made it possible to relate structural changes in the ventricular chamber to changes in cell structure. This study demonstrated that chronic SVT in swine resulted in LV dysfunction and dilatation that was accompanied by significant alterations in myocyte composition and morphology. Chronic SVT produced significant chamber dilatation and increased wall stress, but no change in the LV wt/body wt ratio occurred. The ventricular remodeling associated with SVT is manifested by increased LV chamber and myocardial volume, decreased wall thickness, and lengthening of the myocytes within the free wall. Although absolute LV myocardial volume increased with chronic SVT, total LV myocyte volume, number, and myofibrillar content decreased. Thus, the changes in myocyte composition and structure observed in this study may help explain the LV dilatation and dysfunction observed with chronic tachycardia.
The LV dilatation accompanying chronic SVT did not appear to be associated with chamber hypertrophy. Myocytes from SVT hearts were longer, with a significantly increased cell volume. Although isolated myocyte volume increased with SVT, total LV myocyte volume remained unchanged from control values. These changes in isolated myocyte volume and chamber composition resulted in a significant reduction in the computed number of myocytes within the LV wall. These results suggest that chronic SVT resulted in significant myocyte loss. This laboratory reported previously that chronic SVT is associated with subendocardial fibrosis.5 This past finding and results from the present investigation suggest that chronic SVT caused myocyte injury and subsequent myocytolysis. In the present study, absolute LV myocardial mass and volume increased with chronic SVT. However, this increased LV mass was accompanied by a reduction in myofibrillar volume, no change in total LV myocyte volume, and increased myocardial water content. Thus, the increased LV mass with chronic SVT most likely was not due to an augmentation of contractile elements but to increased myocardial edema.
Chronic SVT resulted in an approximate 32% increase in myocyte volume from control cells. However, the increased cell volume with SVT did not result in chamber hypertrophy, as evidenced by reduced LV wall thickness and no change in total LV myocyte volume or in the LV wt/body wt ratio. The failure of this myocyte volume expansion with chronic SVT to be translated into significant LV hypertrophy probably was due to several factors, including 1) a significant reduction in myocyte number, 2) myocyte slippage within the LV free wall, and 3) reduced cellular composition of myofibrils. The significant reduction in myocyte number with chronic SVT most probably masked the increased myocyte volume at the organ level. The reduction in LV wall thickness with SVT concomitant with increased myocyte volumes suggests that cellular slippage within the ventricular wall also may have contributed to the LV architectural changes with SVT. Side-to-side slippage of myocytes in association with ventricular dilatation recently has been reported after myocardial infarction in rats. 25 We recently have reported that SVT myocytes lose the capacity to bind to basement membrane components.26 These previous results provide a potential mechanism for the myocyte slippage that may have occurred with SVT cardiomyopathy. Finally, the increased myocyte volume with SVT probably was not due to an augmentation of contractile elements, because myofibrillar content significantly decreased.
Rather, the volume expansion of the SVT myocytes probably was due to cellular edema as evidenced by the increased myocardial water content.
Termination of SVT subsequent to the development of LV dysfunction and dilatation resulted in the -no Rni Rn MH by guest on July 11, 2017 http://circres.ahajournals.org/ Downloaded from development of LV hypertrophy and a normalization of LV function and wall stress. Although LV function improved with termination of SVT, there was persistent chamber dilatation. These changes in LV chamber architecture occurred concomitantly with changes in myocyte morphology. In the PST group, the increased LV mass was accompanied by a normalization of the volume percent of myocytes within the LV and the volume percent of myofibrils within the myocytes. These changes in LV mass and composition resulted in significantly increased LV myocyte and myofibrillar volumes in the PST group. In contrast to the SVT group, the increased LV mass in the PST group was due to an augmentation of myocyte volume and contractile elements. These increased LV myocyte and myofibrillar volumes provide a cellular basis for the improvement in LV function observed during early recovery from SVT-induced cardiomyopathy.
In the PST group, isolated myocyte diameter significantly increased, and length remained significantly longer than controls. These changes in myocyte dimensions resulted in a significantly increased myocyte volume from control and SVT values. In contrast to SVT myocytes, the volume expansion of myocytes in the PST group was not due to cellular edema but to significantly increased myofibrillar content. The increased LV mass and total myocyte volume in the PST group probably was not due to significant myocyte hyperplasia, because there was no change in total LV myocyte number from SVT values. Results from this study revealed that augmentation of cell diameter and a persistent lengthening of the myocytes within the LV free wall occurred with the recovery from SVT-induced cardiomyopathy. Therefore, the cellular basis for the changes in LV architecture that occurred after termination of SVT probably were due to 1) increased LV wall thickness associated with an expansion of myocyte diameter and volume, and 2) the residual LV dilatation associated with a persistent increase in myocyte length.
Because the myocyte is the major component responsible for force production and shortening in the heart, changes in structure and volume of myocytes occupying the ventricular wall will result in changes in the capacity for force production and changes in ventricular function. The myocyte remodeling that accompanies changes in hemodynamic loading conditions has been a subject of a large body of research.8-11 [27] [28] [29] [30] [31] [32] [33] [34] [35] on the myocardium will result in increased protein synthesis and growth of the existing myocytes and therefore must involve changes in nuclear DNA. Results from the present study suggest that SVT-induced cardiomyopathy resulted in increased nuclear area; however, a failure of a compensatory response of the SVT myocytes occurred. This increased nuclear area most probably resulted from both increased DNA content and increased nuclear number that occurred with SVT cardiomyopathy.
To our knowledge, this is the first study reporting that nuclear hyperplasia occurs during the recovery from dilated cardiomyopathy. Grove et a127 reported increased [3H]thymidine uptake during the development of myocardial hypertrophy in the rat. These investigators reported that the sites of increased DNA synthesis were in cells located in the interstitium and not within the myocytes themselves. These findings led to the belief that nuclear number and content within the myocyte remain unchanged during the development of hypertrophy. However, more recent studies have reported increased nuclear number, nucleoli, and area in various animal models of hypertrophy.28 '33'34 In the spontaneously hypertensive rat, Clubb et a130 reported that an increase in myocyte length and nuclear number occurred during spontaneous development of hypertrophy in the neonatal rat. Interestingly, these investigators reported these changes occurring before significant increases in systemic blood pressure. Olivetti et a134 reported nuclear hyperplasia after pulmonary artery banding in rats. Anversa et a133 reported that nuclear proliferation occurred after long-standing renal hypertension. Hatt et a128 reported a significant increase in cell volume and the number of nucleoli per nucleus after creation of aorto-caval fistulae in rats. Although nuclear hyperplasia now appears to occur in animal models of hypertension, it also has been reported to occur in humans. Postmortem studies performed in humans have indicated that when the heart is subjected to a chronic load, hyperplasia of myocyte nuclei may occur.36 In the present study, recovery from SVT-induced cardiomyopathy resulted in nuclear hyperplasia concomitant with a significant increase in myocyte volume and LV mass. The nuclear hyperplasia that occurs with termination of SVT most likely is associated with increased DNA synthesis. Therefore, unlike in SVT-induced cardiomyopathy, the increased nuclear number was associated with a compensatory increase in myocyte and myofibrillar volumes, increased LV wall thickness, and a normalization of wall stress.
The findings of this study with respect to nuclear morphology were unexpected. First, it appears that normal swine myocytes contain four nuclei. This is in contrast to cytometric studies of human hearts, which have shown the myocytes to be primarily mononucleated and binucleated.36-38 The majority of studies examining nuclear number and DNA content have been performed in the rat heart during normal growth as well as in several disease states.8,27,28 33, 34 In the normal rat heart, binucleated myocytes commonly are seen, and multinucleated cells also are observed.33,3439 Most researchers examining nuclear content and number within the myocardium in normal and pathological states have used full-thickness sections and stereological techniques.8'10'28 '33-39 In the present study, nuclei were counted from isolated myocytes with the use of a DNA-specific stain, thus allowing direct computation of nuclear number and density. A limitation of the present study is that isolated myocyte volumes were computed from digitized dimension data. This method may have overestimated actual myocyte volumes as compared with more accurate methods such as the Coulter systems.40 However, the important finding from this analysis was that the relative isolated myocyte volume significantly increased with the development and regression of SVT-induced cardiomyopathy.
Damiano and colleagues3 reported that chronic SVT resulted in significant LV chamber dilatation and reduced ejection fraction in dogs. Wilson and associates41 demonstrated that ventricular tachycardia in dogs produced increased left atrial pressures and increased chamber volumes when compared with controls. Recently, we serially examined ventricular function in swine after the induction of SVT and reported that biventricular failure occurred with no change in mass. This present study builds on these previous studies by demonstrating that LV dysfunction and dilatation is accompanied by significant myocyte remodeling. Howard et a16 reported significant chamber dilatation based on echocardiography after rapid ventricular pacing in dogs. More importantly, these investigators reported that termination of tachycardia resulted in hypertrophy and residual chamber dilatation. Our study differs from these previous studies in that atrial pacing was used, and ventricular pressure and dimensions and myocyte composition and morphology were examined. This present study extends the work of previous studies by demonstrating that chronic SVT not only results in LV dilatation and reduced pump performance but is accompanied by significant alterations in myocyte composition and morphology within the ventricular wall. Furthermore, regression from SVT-induced cardiomyopathy results in chamber and myocyte hypertrophy and nuclear hyperplasia.
In summary, chronic SVT produced in swine results in LV dilatation and dysfunction, with elongation of the myocytes within the LV wall. Although increased nuclear area occurs with SVT, there is an absence of a hypertrophic response. Termination of SVT resulted in nuclear hyperplasia and the development of myocyte and ventricular hypertrophy. This hypertrophic response after termination of SVT resulted in normalization of LV function. Thus, changes in LV function and morphology that occur with the development and regression of SVT-induced cardiomyopathy are associated with significant changes in myocyte structure, morphology, and nuclear content.
